ALZHEIMER'S disease (AD) is a common disease oflate ./"\.. life, affecting 5%-10% of the population aged 65 and older (1) . However, the significance ofAD for use of health services has only recently become a topic of research. Prior studies offer conflicting findings on whether AD is associated with an increased risk of hospitalization relative to unaffected elders. These studies have reported greater hospital utilization (2,3) but also no differences or even lower use (4, 5) . A clearer understanding of the association between AD and hospitalization would be valuable for determining the cost of AD care and also for assessing whether people with AD are at risk for receiving less aggressive medical care than other elders (6) .
The Washington Heights-Inwood Columbia Aging Project (WHICAP) offers important data on AD and risk of hospitalization. A total of 2,334 older adults were enrolled in the study in 1992, with follow-up assessments in 1994-95 (n =1520) and 1996-97 (n = 1145). At each follow-up, subjects received neuropsychological, neurologic, and functional assessments, allowing diagnosis ofAD in accord with standardized criteria (7) . In this area of New York City, the majority of hospital care is provided by a single hospital, Columbia-Presbyterian Medical Center (CPMC). Beginning in 1996, an electronic medical records system was established for WHICAP participants. In this system, every hospital admission of a WHICAP subject is flagged, with an electronic mail "alert" sent to the research team. Thus, ascertainment of CPMC hospitalization in this cohort is complete for the period corresponding to the second follow-up survey.
The WHICAP cohort, then, offers important advantages for examining AD and hospitalization.Actual hospital admission data (as opposed to self-or proxy reports) are available,as well as actual diagnoses ofAD (as opposed to results from cognitive screening tests alone). Moreover, the geography and limited medical care of the region link the cohort, for the most part, to a single hospital.
METHODS

Sample
Subjects recruited into WHICAP came from two sources: a stratified random sample drawn from Health Care Financing Administration (HCFA) eligibility files (n = 2124), and targeted recruitment of elders with cognitive impairment drawn from a case reporting system of elders receiving services (n =210).
Sampling strata for this survey included age (65-74, 75-84, 85+), gender, and race-ethnicity (Hispanic, non-Hispanic black, nonHispanic white). For the HCFA-based survey, systematic replicate subsamples were drawn using random starts, such that each subsample contained age and racial-ethnic groups of equal size. The response rate for the entire sample at baseline was 70% (8) (9) (10) .
All WHICAP subjects alive at the beginning of the hospital reporting period (January, 1996) were included in this study (N = 2003) . These subjects represent 85.8% of the original cohort.
Measures
Alzheimer's disease status.-All WHICAP subjects completed a full battery of neuropsychological tests. Subjects meeting neuropsychological criteria for AD (7, 11, 12) were examined by a neurologist. In addition, a random sample of 25% of nonde-mented subjects were also examined by neurologists. Severity of AD was staged according to the Oinical Dementia Rating (CDR) scale (13) . In this staging system, physicians rate patient function along six dimensions and derive a composite score indicating mild, moderate, severe, profound, or terminal disease. We divided subjects with AD into two groups, those with mild-moderate disease (CDR 1-2) and those with more severe disease (CDR 3+). For these analyses, we used the last diagnosis available. Of the total WHICAP cohort, 1,978 (98.8%) were diagnosed.
Hospitalizationeventmonitoring system -The hospital admissions period monitored extended from January 1, 1996, to September 30, 1997, a period of21 months. The CPMC electronic reporting system documented subjects' admissions, length of stay for each admission, and discharge diagnoses. The e-mail alert program was created by the CPMC Department of Medical Informatics as part of an effort to use medical records more effectively for clinical and epidemiological research. Once an alert was received, subjects' hospital stays were monitored; research physicians reviewed patients' charts and coded discharge diagnoses into 1 of 11 categories: surgery, metabolic/nutritional disorders, trauma, pneumonia, other infections, cardiovascular disease, cerebrovascular disease, malignancy, hip fracture, other, or unknown.
Number of hospitalizations was recorded for each subject, along with a dichotomous variable indicating "no" or "any" hospitalization in the reporting period. Length of stay was calculated by summing the number of days spent in the hospital across discrete admissions.
Reported hospitalizations: concurrent second follow-up survey.-During the period in which CPMC hospitalizations were electronically monitored, the WHICAP sample also underwent a concurrent, second follow-up survey assessment, in which information was collected from 1,145 respondents or their proxies. At this assessment, subjects or proxies reported on hospitalizations that occurred throughout the prior year, both at CPMC and elsewhere. For subjects whose admission dates preceded the interview date, we compared self-or proxy-reported CPMC hospitalizations to CPMC admission records. We also examined reports of admissions to other hospitals in the region (Harlem Hospital Center, Montefiore, St. Luke's-Roosevelt, Mt. Sinai, and Bronx VA). Using these data, we examined the proportion of hospitalizations that occurred at CPMC and whether subjects with AD differed from unaffected subjects in the likelihood of a CPMC hospitalization.
Assessment ofmedical comorbidities.-A subset ofWH-ICAP subjects received a medical examination by research team physicians as part of their follow-up. For these patients, physicians conducted exams, inspected medications, and interviewed patients and proxies about medical conditions. Physicians recorded the presence or absence of 12 medical conditions (myocardial infarct/ischemic heart disease, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive pulmonary disease, peptic ulcer, liver disease, diabetes, renal disease, and systemic malignancy).
A modified comorbidity index was calculated following Charlson's recommendations (14) . The Charlson index weights comorbid conditions by the strength of their association with mortality; a weighted sum is then calculated. Following this approach, chronic liver disease, chronic obstructive pulmonary disease, gastrointestinal disease, myocardial infarction, diabetes, peripheral vascular disease, stroke, arthritis, and hypertension were all assigned a weight of 1; chronic renal disease and systemic malignancy were assigned a weight of 2. Subjects were then categorized according to the following scores: 0 (no comorbid condition), 1 (one comorbid condition), 2 (two comorbid conditions or one of the more severe conditions), 3+ (three or more conditions, or at least one severe condition with another condition). For this measure we used subjects' last medical examination, which was available for 1,034 subjects.
Information on psychiatric comorbidity was also collected for subjects meeting criteria for AD. For this assessment, subjects' proxies completed the Columbia University Scale for Psychopathology in Alzheimer's Disease (CUSPAD), which records the presence of psychiatric symptoms common in AD patients (15) .
Analyses
Total hospital use and CPMC admissions.-WHICAP subjects and proxies were asked to report all hospital use and site(s) of hospitalization. We calculated the proportion of total hospital use accounted for by CPMC admissions and whether subjects with AD differed from unaffected subjects in the likelihood of a CPMC admission.
Comparison ofmedical recordadmissionsto interview-reported admissions.-Subject and proxy reports of CPMC hospitalization were cross-classified with electronic hospital admission data. The sensitivity and specificity of reported admissions were calculated using the electronic medical record as the criterion.
Rates ofCPMC admission.-The proportion of subjects with a CPMC medical record admission over the reporting period was calculated for unaffected subjects, subjects with mild or moderate AD, and subjects with severe AD. In addition, other predictors of hospital admission were examined, including sociodemographic status (gender, age, education, race-ethnicity), number of comorbid medical conditions (modified Charlson index), and whether subjects died during the reporting period. The last is an important predictor because a large proportion of hospital care involves end-of-life care (16) . Multivariate logistic models were developed to examine predictors of hospitalization and to determine ifAD diagnosis was a significant, independent predictor of hospitalization, controlling for these other factors.
Features of AD potentially associated with hospitalization.-Because psychiatric morbidity is a feature ofAD and may also bea cause of hospitalization, AD subjects who were hospitalized in the reporting period were compared to those who were not to determine if levels of psychiatric symptoms differed. Discharge diagnoses of AD and non-AD patients were also compared to determine if subjects with AD were hospitalized for different conditions than elders without AD.
REsULTS
Total hospital use and CPMC admissions.-In the WHICAP cohort, 263 of the 2,003 subjects (13.1 %) were admitted to CPMC, as documented by the electronic reporting system, over the 21-month reporting period. Number of admissions among these subjects ranged from 1 to 11, but 61.6% had a single admission over this period.
Total length of stay, summated, when necessary, over repeated admissions, ranged from 1 to 158 days. Median total length of stay was 8 days.
Information obtained from subject interviews suggests that the CPMC electronic records system captured the majority of hospitalizations in the cohort. Of the 1,145 subjects completing an in-person interview in 1996-97, 20.1 % reported at least one hospitalization and 63% of these were reported as CPMC admissions. AD and non-AD WHICAP subjects (or proxies) were equally likely to report CPMC as the site of hospitalization (71% and 61% of reported hospitalizations, respectively,p = .20).
Comparison of medical record admissions to interviewreported admissions.-Comparing interview-reported CPMC admissions to admissions documented in the electronic records system showed that the sensitivity of interview reports was 69.8% and specificity was 92.5%.
Finally, the subjects who died in the reporting period (2.8%) were also more likely to have had a CPMC admission reported in the electronic records system. Of the subjects who died, 21.4% had been admitted to CPMC in the 21 months of the reporting period, compared to 12.8% of those who did not die in this period (p =.06). Subjects with AD were also more likely to die in this period than subjects who did not meet criteria for AD (5.4% vs 2.1%,p < .001).
Multivariate analyses of hospitalization.-Multivariate logistic regression models showed that more advanced AD was a significant risk factor for hospitalization independent of sociodemographic factors, comorbid medical status, and death in the reporting period. This finding is shown in Table 2 , which presents two models, one without comorbid medical status as a predictor (n =1978) and one including this predictor (n =993), because of the different sample sizes used in constructing the two models.
In both models, severe AD was an independent predictor of hospitalization (Modell: OR 2.3; 95% CI: 1.3,4.0; Model 2: OR 2.3,95% CI: 1.1,4.6). In neither model was mild-moderate AD Rates ofCPMC admission.-Characteristics of subjects who had a medical record-documented CPMC admission over the reporting period are shown in Table 1 .
Men and women were equally likely to have a hospitalization (13.5% of males in the cohort were hospitalized, compared to 12.9% offemales,p = .74). Risk of hospitalization increased with age, ranging from 11.7% among those younger than 70 to 17.9% among those 85 and older; however, this relationship did not achieve statistical significance (p = .11). Risk of hospitalization also did not differ among ethnic-racial groups: 12.1% of the whites, 11.4% of the African Americans, and 14.7% of the Hispanics had a CPMC admission during this period. By contrast, level of education was a significant predictor of hospitalization. Of the WHICAP subjects who had completed high school, 10.4% had a CPMC hospitalization in the reporting period, compared to 15.8% and 16.0% among subjects whose education did not go beyond elementary school (p < .03).
Of the 2,003 WHICAP subjects alive at the beginning of the electronic medical record monitoring period, 99 (4.9%) were residing in nursing homes. CPMC hospitalization rates, as indicated by the electronic medical record, were higher among these subjects (17.2%) than among non-nursing home subjects (12.9%), but this difference did not achieve statisticalsignificance (p = .22).
Comorbid conditions were strongly associated with risk of hospitalization: 8.9% of subjects with no comorbid conditions at their last assessment were hospitalized, compared to 18.1% among subjects with a Charlson score of 1, 19.7% among subjects with a score of 2, and 25.1 % among subjects with scores of 3 or more on the index (p < .0001).
AD was also associated with a significant increase in the risk of hospitalization over the reporting period. Of subjects with AD, 17.5% were hospitalized, compared to 11.9% of subjects without AD (p < .01). This risk increased with severity of AD, as indexed by CDR scale score. While 11.9% of subjects without AD had a CPMC admission, the risk was 15.9% for subjects with dementia of mild or moderate severity (odds ratio [OR] 1.4,95% confidence interval [CI]: 1.0, 1.9) and 26.4% for subjects with advanced dementia (OR 2.7,95% CI: 1.5,4.6).
significantly associated withhospitalization. Higherscoreson the comobidity index were also significantly associatedwith risk of hospitalization, and low educationremained a significant predictor evenwithinclusion of comorbid medicalstatus in the model.
Number ofhospitalizations and hospital length ofstay.-For
people with documented admissions to CPMC, we examined number of hospitalizations and total length of stay by AD status and scores on the comorbidity index. While AD severity predictedrisk of hospitalization, severity was not significantlyassociated with number of hospitalizationsor length of stay.Both AD and non-AD patients with CPMC admissions averaged about two admissions.Likewise,length of stay across these admissions did not significantly differ. Subjects withoutAD spent a mean of 17.6 days in the hospital, compared to 14.4 days among patients with mild-moderateAD, and 14.9 days among patients with severeAD.
By contrast, comorbidmedical status was stronglyassociated withnumberof admissions and lengthof stayamongsubjects hospitalizedin the reporting period. For these subjects, the numberof admissions was 1.3amongsubjects withno comorbidities, 1.7for subjects with scoresof 1,2.0 for subjects with scores of 2, and 2.6 for subjects with scores of 3 or more on the modified Charlson index(p < .01).Similarly, totallengthof stay was 10.3, 14.3,20.8, and 25.2days,respectively, according to Charlson score (p < .03).
Table2. Predictors of Hospitalization:
Multivariate LogisticRegression *Note: OR = odds ratio; CI = confidence interval.
Features ofAD relevantfor hospitalization.-Discharge diagnoses for AD and non-AD groups were similar except in the case of infectious disease. Of subjects with AD who were hospitalized, 40.8% had pneumonia or other infectious disease as their coded discharge diagnosis, compared to 27.2% among subjectsnot meeting criteria for AD (p < .05).
Psychiatric morbidity,a common feature of AD, was also examined as a cause of the increasedlikelihoodof hospital admissionsamongsubjectswithAD. However, hospitalized elderswith AD did not showa significantly higherprevalence of psychiatric symptoms or behavioralagitation thanelders withAD who were not hospitalized (25.5%vs 20.0%,respectively, p = .29).
Finally, we examined hospital use among AD and non-AD subjectswho died in the follow-upperiod.Among subjectswho died in the reporting period, subjectswith AD were more likely to have been hospitalized than subjects without AD. Seven out of 22 (31.8%)of AD subjects who died were hospitalizedin the reporting period, compared to 5 out of 34 (14.7%) of non-AD subjects who died (p < .01). The time between first hospitalization and death ranged from 13 to 368 days and did not significantly differbetweenAD and non-AD subjects.
DISCUSSION
This community-based study shows that elders meeting criteria for AD face an increased risk of hospitalization relative to cognitively normal elders; 17.5% of subjects with AD were hospitalized at Columbia-PresbyterianMedical Center over 21 months, compared to only 11.9% of subjects without AD. These rates do not account for all hospitalizations, but only those occurringat CPMC. Data collectedduring the concurrent survey suggestthat these hospitalizations account for about two thirds of all subjects who were hospitalized (71% of AD subjects, 61% of non-AD subjects). We can therefore impute total hospital use. With such an imputation, the annual risk of hospitalization was 11.1% among non-AD patients, 14.1% among all AD patients, and 21.2% for subjects with severe AD, as defined by a CDR score of 3+.
The elevatedrisk of hospitalizationassociated with more advanced dementia was independent of other factors associated with hospitalization, such as age, education, comorbid conditions, and subsequent mortality. The increased risk, therefore, appears to be specific to advanced AD, although not explained by the psychiatric morbidity typical of the disease or the increased risk of death associated with AD. AD patients admitted to CPMC and AD patients without an admission were equally likely to have psychiatric symptoms,and severeAD was significantly associated with hospitalization even when controlling for death in the follow-up period.
AD patients who were hospitalized differed from non-AD patients hospitalized in the same period (and at the same hospital) in only one discharge diagnosis, infectious disease (40.8% vs 27.2%), as coded by physicians who inspected discharge diagnoses. Therefore, we conclude that at least part of the excess risk of hospitalizationassociated withAD is likely due to an increased risk of infection-in particular, pneumonia, requiring hospital treatment. It is possible, however, that infections coded on the dischargediagnosis may also have had a nosocomial origin. We are currentlyinvestigating this issue.
An important feature of this community-based study is its use of hospitaladmissions records, rather than self-or proxy.re-ports, in a geographic area where a single hospital is the major sourceof hospitalcare. The proportionof AD and non-AD subjects (or proxies) in Washington Heights-Inwoodwho reported CPMC as the site of hospital admission in a concurrent interview did not significantly differ. Thus, it appears that the two groups were equally likely to use CPMC for hospital care. Another important aspect of the study is its use of actual diagnoses of AD based on a full batteryof neuropsychological tests and neurologic examination. Prior population-based studies have relied, for the most part, on screening tests to identify older adultswith cognitive impairment (2, 3) .Other studies have addressedthe risk of hospitalization among AD patientsbut relied on patients drawn from AD registries or research centers and did not include information on rates of hospitalization amongelders withoutAD (5) .
The most relevant study for comparisonis the Monongahela ValleyIndependent Elders Survey,which is population-based and which included hospitalization as an outcome (3). However, the Monongahela Valleystudy did not diagnose AD but rather defined "cognitive impairment" empirically. Cognitive impairmentwas definedas a score below the 5th percentile of the sample distribution for the Mini-Mental State Examinationor for two other cognitivetests, including one test of memory. By this standard,Ganguli and colleagues (3) found that 19.1% of cognitively impaired elders were hospitalized over a 6-month period, compared to 10.2% of unimpaired elders. These rates were based upon subject or proxy reports of hospitaluse, and the greaterrisk for hospitalization amongcognitivelyimpaired elders was no longer significantin multivariate models. In the WHICAP cohort, by contrast, advancedAD remained a significant risk factor for hospitalization in multivariatemodels that included sociodemographic factors,comorbid conditions, and death duringthe follow-up period.
Despite the increased risk of hospitalization associated with advanced AD in the WHICAP cohort, we did not find an increasedlength of stay or increasednumber of admissionswhen we limited analyses to patients who had been admitted to the hospital. This contrasts with findings reported by Weiler and colleagues (2), who reported that "moderate/severe" cognitive impairment was associatedwith an increasedrisk of longerhospital staysin the late 1980s. Perhapsbecauseof changingtrends in hospital care, severely affected AD patients in WHICAP were more likely to be hospitalizedbut not more likely to have longerlengthof stays once admitted.
Our results suggest that severeAD is a significant,independent risk factor for hospitalization.For severeAD, then, we do not findevidencethat aggressive care, at least as it is indexedby hospital admissions, is limited. This finding supports research reportedby Friedand Gillick (6) .Theyfoundthatfamily caregivers were likely to limit aggressive care for elders with terminaldisease and for elders in institutional settings, but found no such limitation for elderswith dementia living in community settings.
